RecruitingPhase 2NCT06401317

Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA)

Comparison of the Efficacy of Intra-Articular Corticosteroid Injections Versus Saline Solution for Thumb Osteoarthritis: Double-Blind Pragmatic Randomized Pilot Study


Sponsor

Université du Québec à Trois-Rivières

Enrollment

40 participants

Start Date

Nov 4, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Thumb osteoarthritis or trapeziometacarpal osteoarthritis (TMO) is a common and painful form of hand arthritis that limits thumb mobility and hand function, affecting patients' quality of life. Although corticosteroids injections are a typical treatment, their effectiveness has been challenged, and side effects have been reported. Recent studies suggest that saline injections, usually considered inactive, might be a viable treatment option. The primary goal of this study is to compare the effectiveness of saline injections versus corticosteroids injections in reducing TMO-related pain and improving hand function. In this study, 40 people with TMO will be randomly assigned to receive either a corticosteroids or a saline injection, without them or the doctors performing the injection knowing which one was administered (double blind). If saline injections prove more effective, they could provide a less harmful and cheaper therapeutic alternative for TMO patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • aged ≥18 years;
  • diagnosis of TMO was confirmed by X-ray interpreted by a radiologist;
  • suffering from pain at the base of the thumb;
  • the attending physician deems that an intra-articular corticosteroid injection would be beneficial, rather than opting for other types of intervention such as surgery
  • can read, understand and answer in either French or English.

Exclusion Criteria4

  • having received one or more corticosteroid injections in the last 12 months or surgery on the affected thumb;
  • suffering from painful thumb caused by a trauma (e.g., fracture, sprain), rheumatoid arthritis, or De Quervain's tendonitis; and
  • being pregnant or breastfeeding; and
  • known allergies to any components of the solutions (triamcinolone acetonide, benzyl alcohol, carboxymethylcellulose sodium, hydrochloric acid, polysorbate, sodium chloride, or sodium hydroxide) or to iodinated contrast media.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSaline Solution (NaCl 0,9%)

Ultrasound/fluoroscopy-guided intra-articular injection of 0.25ml of 0.9% saline solution.

DRUGTriamcinolone Acetonide

Ultrasound-guided intra-articular injection 0.25ml (10 mg) of triamcinolone.


Locations(2)

Centre Hospitalier de l'Université de Montréal - Physiatry

Montreal, Quebec, Canada

Centre Hospitalier de l'Université de Montréal - Chirurgie plastique

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06401317


Related Trials